Table 2.
Group R | Group RN | Group RK | |
---|---|---|---|
Duration of analgesia, median (98.3% CI) (min) | 320.0 (308.5–332.0) | 829.5 (780.0–860.0) | 820.0 (812.0–877.0) |
Difference | |||
Compared with group R (median) (98.3% CI), mina | NA | –492.0 (–526.8 to –459.0) | –513.0 (–539.2 to –489.4) |
P valueb | P < 0.001 | P < 0.001 | |
Compared with group RN, median (98.3% CI) (min)a | NA | NA | –19.5 (–49.1 to 11.2) |
P valueb | P = 0.83 | ||
Compared with group RK, median (98.3% CI) (min)a | NA | NA | NA |
P valueb |
NA not applicable, CI confidence interval, R ropivacaine, RN ropivacaine + nalbuphine, RK ropivacaine + ketorolac
aConfidence intervals were calculated by Hodges-Lehmann estimation to estimate the median difference
bP values were calculated using Kruskal–Wallis test